ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

It’s all about the (stem cell) neighborhood – EurekAlert (press release)

Continue reading

2018-04-06 Michael Zand NEWS

It’s all about the (stem cell) neighborhood – EurekAlert (press release)


EurekAlert (press release)

It’s all about the (stem cell) neighborhood
EurekAlert (press release)
A team headed by Gedas Greicius and Professor David Virshup, Director of the Programme in Cancer & Stem Cell Biology in Duke-NUS Medical School, studied the source and functional role of Wnts and RSPO3 [1]. RSPO3 is by far the most abundant R-spondin …
Mechanism vital to keeping blood stem cells functional uncoveredScience Codex
Why cells with identical genes perform unique jobs — ScienceDailyScience Daily

all 13 news articles »

Continue reading

2018-04-06 Michael Zand NEWS

It’s all about the (stem cell) neighborhood – EurekAlert (press release)


EurekAlert (press release)

It’s all about the (stem cell) neighborhood
EurekAlert (press release)
A team headed by Gedas Greicius and Professor David Virshup, Director of the Programme in Cancer & Stem Cell Biology in Duke-NUS Medical School, studied the source and functional role of Wnts and RSPO3 [1]. RSPO3 is by far the most abundant R-spondin …
Mechanism vital to keeping blood stem cells functional uncoveredScience Codex
Why cells with identical genes perform unique jobs — ScienceDailyScience Daily

all 13 news articles »

Continue reading

2018-04-06 Michael Zand NEWS

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis 2018-2030 – ResearchAndMarkets.com – Business Wire (press release)

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis 2018-2030 – ResearchAndMarkets.comBusiness Wire (press release)Approximately 15.2 Million incidences of cancer were registered in 2015. This number is forecasted to reach an approxim… Continue reading

2018-04-06 Michael Zand NEWS

Incyte’s cancer drug fails trial, marking major blow for immunotherapy combination treatment – STAT


EurekAlert (press release)

It’s all about the (stem cell) neighborhood
EurekAlert (press release)
Stems cells in our adult tissues live in very specific locations called stem cell niches. These niches provide a specialised, ideal neighbourhood for stem cells. The stem cells in the niche are undifferentiated, meaning they have not yet changed into a …

and more »

Continue reading

2018-04-06 Michael Zand NEWS

Synthetic Biology Market Key Players: DuPont, Inc., Agrivida, Inc., GeneWorks Pty Ltd. – Pharmaceuticals News

Pharmaceuticals NewsSynthetic Biology Market Key Players: DuPont, Inc., Agrivida, Inc., GeneWorks Pty Ltd.Pharmaceuticals NewsThe report compiled by Zion Market Research offers a forecast on the “Synthetic Biology Market– Global Industry Perspective, … Continue reading

2018-04-06 Michael Zand NEWS

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis … – Markets Insider

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis …Markets InsiderAccording to report on Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis, T-cell Immunotherapy is a rapidly expanding field of oncology. This th… Continue reading

2018-04-06 Michael Zand NEWS

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis Report 2018 Featuring Key Players – Novartis … – PR Newswire (press release)

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis Report 2018 Featuring Key Players – Novartis …PR Newswire (press release)According to report on Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis, T-cell Immuno… Continue reading

2018-04-06 Michael Zand NEWS
  • 1
  • …
  • 289
  • 290
  • 291
  • 292
  • 293
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

STAT

Incyte’s cancer drug fails trial, marking major blow for immunotherapy combination treatment
STAT
he first real clinical test of the cancer immunotherapy combination thesis has come back negative. Incyte said Friday that its experimental drug epacadostat failed to improve the efficacy of Merck’s checkpoint inhibitor Keytruda when the two drugs were …
Incyte tumbles after combo therapy with Merck fails studyCNBC
Incyte slumps 19% after combo therapy fails late-stage testFinancial Times
Incyte, Merck & Co. Halt Phase III Trial After Epacadostat/Keytruda Combination Fails in MelanomaGenetic Engineering & Biotechnology News
Benzinga –Business Insider Australia
all 146 news articles »